advertisement

Topcon

Nilforushan N 11

Showing records 1 to 11 | Display all abstracts from Nilforushan N

104322 The effect of the hypertensive phase on the long-term outcomes of Ahmed glaucoma valve (AGV) implantation
Nilforushan N
International Ophthalmology 2022; 42: 3739-3747
104363 Subtenon triamcinolone injection to treat serous choroidal detachment after glaucoma surgery: A case series
Nilforushan N
European Journal of Ophthalmology 2022; 0: 11206721221108253
104322 The effect of the hypertensive phase on the long-term outcomes of Ahmed glaucoma valve (AGV) implantation
Hassanpour K
International Ophthalmology 2022; 42: 3739-3747
104363 Subtenon triamcinolone injection to treat serous choroidal detachment after glaucoma surgery: A case series
Abolfathzadeh N
European Journal of Ophthalmology 2022; 0: 11206721221108253
104322 The effect of the hypertensive phase on the long-term outcomes of Ahmed glaucoma valve (AGV) implantation
Hassanpour K
International Ophthalmology 2022; 42: 3739-3747
104363 Subtenon triamcinolone injection to treat serous choroidal detachment after glaucoma surgery: A case series
Abolfathzadeh N
European Journal of Ophthalmology 2022; 0: 11206721221108253
104322 The effect of the hypertensive phase on the long-term outcomes of Ahmed glaucoma valve (AGV) implantation
Hassanpour K
International Ophthalmology 2022; 42: 3739-3747
104363 Subtenon triamcinolone injection to treat serous choroidal detachment after glaucoma surgery: A case series
Najafzadeh F
European Journal of Ophthalmology 2022; 0: 11206721221108253
104322 The effect of the hypertensive phase on the long-term outcomes of Ahmed glaucoma valve (AGV) implantation
Vafaei F
International Ophthalmology 2022; 42: 3739-3747
104363 Subtenon triamcinolone injection to treat serous choroidal detachment after glaucoma surgery: A case series
Samimifar D
European Journal of Ophthalmology 2022; 0: 11206721221108253
104322 The effect of the hypertensive phase on the long-term outcomes of Ahmed glaucoma valve (AGV) implantation
Yadgari M
International Ophthalmology 2022; 42: 3739-3747

Issue 23-2

Change Issue


advertisement

Oculus